Check brain and behavior markers during sulforaphane in autism
Part of Mental health clinical trials.
This study tests whether “digital biomarkers” (measurable signs from digital devices) change during treatment with sulforaphane, which is found in certain broccoli extracts. It may help researchers better understand which signals track response in young men with autism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of autism (“autistic disorder,” not another autism label)
- You are a male age 13 to 30
- You previously participated in the earlier study NCT02677051
- You have not started or continued Avmacol or similar broccoli-extract products since leaving that double-blind study
- A parent or legal guardian can consent for you (if applicable)
- You can attend all study visits and follow the study treatment plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood samples from children (and sometimes parents) to see if certain protein patterns can help identify or better understand autism spectrum disorder. The results could support finding “biomarkers,” which are measurable signs that may guide future research or care.
This trial is looking at the connection between the gut and autism. It tests whether certain gut bacteria and the gut's protective barrier are different in children with autism and gastrointestinal issues. This could help find new ways to improve symptoms.
This study looks at the connection between the bacteria in a child's gut and their development and behavior. It may help researchers understand if gut health plays a role in autism symptoms.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This study is testing whether a probiotic supplement called Limosilactobacillus Reuteri might help reduce social difficulties in children with autism. It may offer a new way to support your child's social development.
This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.
Hear when a new Autism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.